Thai
Thai
Thai
The ERA Test is a procedure that assesses the readiness of the endometrium at the genetic level to identify the optimal time when the uterus is most receptive to embryo implantation. This procedure is suitable for individuals experiencing infertility, those who have previously undergone embryo transfer with good-quality embryos without success, or those with a limited number of embryos. The results can help doctors plan and determine the optimal timing for embryo transfer more precisely, which may help reduce the risk of embryo loss and improve the chances of a successful pregnancy.
Endometrial receptivity is determined not only by whether the uterine lining has an appropriate thickness, but also by the timing when the endometrium is most receptive to embryo implantation. The ERA Test analyzes gene-level data from the endometrium to assess the optimal timing and provide information to support personalized embryo transfer planning.
In cases where a previous embryo transfer was unsuccessful, even after the embryo and uterine cavity have been evaluated, assessing endometrial receptivity may provide additional information for consideration. The ERA Test analyzes gene expression in the endometrium to determine whether the timing of embryo transfer corresponds with the period when the endometrium is receptive.
The results of the ERA Test can be used to help determine the duration of hormone exposure and the optimal timing for embryo transfer, particularly for individuals who require a more personalized treatment plan. The test results are considered together with embryo-related information and individual reproductive factors before determining the treatment plan.
Successful embryo implantation does not depend solely on endometrial receptivity. It also involves the quality and developmental stage of the embryo. Therefore, embryo transfer planning needs to consider the synchronization between the “Embryo” and the “Endometrium” so that both factors are within the appropriate window for the implantation process.
ERA Test results are medical information that must be considered together with the patient’s treatment history, uterine cavity assessment, embryo information, and other individual factors. The doctor therefore plays an important role in using the test results to help plan the timing of embryo transfer appropriately for each individual.
The ERA Test (Endometrial Receptivity Analysis) is a medical procedure that helps assess the readiness of the endometrium for embryo implantation. The process begins by preparing the endometrium through the administration of female hormones or progesterone (Progesterone), which is given for approximately 5 days. An endometrial biopsy is then performed to collect a tissue sample from the uterine lining. The sample is analyzed for gene expression involving more than 248 genes to identify the precise timing for transferring the embryo into the uterine cavity. This method may help increase the chance of embryo implantation and ultimately lead to pregnancy.
The ERA Test is particularly important for women who are planning to have children, as it may help improve the chances of pregnancy. It is especially relevant for those who have been trying to conceive naturally for a long time without success, as well as those who have previously undergone embryo transfer without achieving pregnancy. In these cases, the endometrium may have been assessed as potentially not being receptive or ready for embryo implantation at that time.
Since the ERA Test assesses the readiness of the endometrium for embryo implantation, certain conditions related to embryo selection may need to be considered. These can be divided into two important factors:
This means that an effective ERA Test process should not rely solely on endometrial receptivity. The embryo must also be in an appropriate condition, including its developmental stage and chromosomal status, to support a successful pregnancy.
ERA Test results can generally be divided into three main categories:
Information from these three categories is important for treatment planning. The alignment between the ERA Test results and embryo transfer timing can help doctors determine the appropriate window when the endometrium is receptive, which may increase the chance of successful embryo implantation in the next fertility treatment cycle.
The ERA Test is a detailed procedure that requires a high level of precision and accuracy. It may be particularly suitable for:
The ERA Test helps assess the optimal timing for embryo transfer, which is one of the important factors affecting pregnancy. This may be particularly relevant for individuals who have previously undergone embryo transfer without success. Adjusting the timing to match the window of implantation may help improve the chance of pregnancy based on each individual’s circumstances.
A general assessment typically evaluates the thickness and appearance of the endometrium through ultrasound. The ERA Test, on the other hand, assesses endometrial receptivity by analyzing gene expression to identify the period when the endometrium is receptive to embryo implantation. This provides more in-depth information that doctors can consider when planning treatment for more complex cases.
If the results indicate that the endometrium is not receptive, the doctor may calculate and adjust the duration of hormone administration or determine a new embryo transfer date to align with the optimal timing for that individual. This approach addresses the timing factor and helps avoid transferring the embryo when the uterus is not yet receptive.
No, it is not necessary for everyone. Doctors may recommend the test in specific cases, such as individuals who have undergone multiple transfers of good-quality embryos without achieving pregnancy or those with no clear cause of infertility. For general cases where treatment has just begun or embryo transfer has not yet been attempted, the ERA Test may not be necessary as an initial step.